Rexahn Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch REXN and buy or sell other stocks, options, and ETFs commission-free!About REXN
Ocuphire Pharma, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders.
CEOGeorge Magrath, III, MD
CEOGeorge Magrath, III, MD
Employees14
Employees14
HeadquartersFarmington Hills, Michigan
HeadquartersFarmington Hills, Michigan
Founded2018
Founded2018
Employees14
Employees14
REXN Key Statistics
Market cap61.86M
Market cap61.86M
Price-Earnings ratio-4.24
Price-Earnings ratio-4.24
Dividend yield—
Dividend yield—
Average volume180.21K
Average volume180.21K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$6.60
52 Week high$6.60
52 Week low$1.85
52 Week low$1.85